Grierson J, de Visser R, Bartos M
Australian Research Centre in Sex, Health & Society, La Trobe University, 215 Franklin Street, Melbourne VIC 3000, Australia.
Int J STD AIDS. 2001 Oct;12(10):670-6. doi: 10.1258/0956462011923903.
The aim of this study was to assess whether the lives of Australian people living with HIV/AIDS (PLWHA) have improved to the extent hoped for following the introduction of new antiretroviral (ARV) drugs for HIV. In 1997, 925 Australian PLWHA completed the first national survey of the social impacts of HIV/AIDS. In 1999, 924 Australian PLWHA were recruited for a repeat of the survey. Study participants completed an anonymous self-administered questionnaire. The data revealed that although new ARV drugs have improved the clinical profiles of many PLWHA, there have not been corresponding improvements in the physical well-being, levels of employment, or financial circumstances of many PLWHA. Nevertheless, PLWHA express favourable attitudes toward ARV drugs. Australian PLWHA have a complex relationship with their ARV medication that is likely to change over time as their HIV disease progresses and new treatments become available.
本研究的目的是评估在引入用于治疗艾滋病毒的新型抗逆转录病毒（ARV）药物之后，澳大利亚艾滋病毒/艾滋病感染者（PLWHA）的生活是否已改善到预期程度。1997年，925名澳大利亚PLWHA完成了首次关于艾滋病毒/艾滋病社会影响的全国性调查。1999年，924名澳大利亚PLWHA被招募参与该调查的重复研究。研究参与者完成了一份匿名的自填式问卷。数据显示，尽管新型ARV药物改善了许多PLWHA的临床状况，但许多PLWHA的身体健康、就业水平或经济状况并未得到相应改善。尽管如此，PLWHA对ARV药物持积极态度。澳大利亚PLWHA与其ARV药物之间存在复杂的关系，随着他们的艾滋病毒病情进展以及新治疗方法的出现，这种关系可能会随时间而改变。
